AE Wealth Management’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$450K Buy
+2,003
New +$499K ﹤0.01% 1165
2024
Q1
Sell
-6,597
Closed -$1.25M 1802
2023
Q4
$1.25M Buy
6,597
+24
+0.4% +$3.69K 0.01% 1072
2023
Q3
$972K Buy
6,573
+1,738
+36% +$314K 0.01% 1109
2023
Q2
$1.06M Buy
4,835
+192
+4% +$42.8K 0.01% 1073
2023
Q1
$1.02M Buy
4,643
+147
+3% +$31.9K 0.01% 1033
2022
Q4
$936K Buy
4,496
+522
+13% +$115K 0.01% 1015
2022
Q3
$868K Sell
3,974
-408
-9% -$92.9K 0.01% 998
2022
Q2
$919K Buy
4,382
+797
+22% +$170K 0.01% 917
2022
Q1
$869K Buy
3,585
+30
+0.8% +$7.26K 0.01% 962
2021
Q4
$926K Buy
3,555
+1,646
+86% +$427K 0.01% 953
2021
Q3
$503K Buy
1,909
+92
+5% +$25.2K ﹤0.01% 1169
2021
Q2
$448K Sell
1,817
-553
-23% -$116K ﹤0.01% 1178
2021
Q1
$460K Buy
2,370
+87
+4% +$17.4K ﹤0.01% 1061
2020
Q4
$485K Buy
2,283
+310
+16% +$61.8K 0.01% 975
2020
Q3
$338K Buy
1,973
+289
+17% +$53.4K ﹤0.01% 999
2020
Q2
$323K Buy
1,684
+202
+14% +$33K 0.01% 998
2020
Q1
$218K Sell
1,482
-1,280
-46% -$204K 0.01% 980
2019
Q4
$428K Buy
2,762
+470
+21% +$67.7K 0.01% 786
2019
Q3
$310K Buy
+2,292
New +$300K 0.01% 772

Other funds holding RMD

AE Wealth Management's RMD Position: Q1 2026 in Review

AE Wealth Management opened a new position in ResMed (RMD) in Q1 2026: 2,003 shares worth $450K. The stake represents ﹤0.01% of the portfolio and ranks #1165 among its holdings. This is a return to the name: AE Wealth Management previously reported a position in RMD as recently as Q4 2023.

AE Wealth Management first reported a position in RMD in Q3 2019 and has held it in 19 quarters since. The position peaked at $1.25M in Q4 2023. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • AE Wealth Management held 2,003 shares of ResMed worth $450K as of Q1 2026.
  • ResMed was a new AE Wealth Management position in Q1 2026.
  • ResMed made up ﹤0.01% of AE Wealth Management's portfolio in Q1 2026, its #1165 holding.
  • AE Wealth Management first reported a position in ResMed in Q3 2019 and has held it in 19 quarters since.
  • AE Wealth Management's ResMed position peaked at $1.25M in Q4 2023.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on AE Wealth Management's 13F filing for Q1 2026, filed 13 May 2026.